| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients
|
Salgado, Mª A. Vaz
|
|
2016
|
19 |
3 |
p. 357-363
|
artikel
|
| 2 |
Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?
|
Lester, A.
|
|
2016
|
19 |
3 |
p. 273-278
|
artikel
|
| 3 |
Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI)
|
Capdevila, J.
|
|
2016
|
19 |
3 |
p. 279-287
|
artikel
|
| 4 |
Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions
|
Salvador, J.
|
|
2016
|
19 |
3 |
p. 341-356
|
artikel
|
| 5 |
European edition of the NCCN clinical practice guidelines: relevance of the translation and adaptation into Spanish
|
Guillem, V.
|
|
2016
|
19 |
3 |
p. 288-290
|
artikel
|
| 6 |
Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib
|
Lamarca, A.
|
|
2016
|
19 |
3 |
p. 364-372
|
artikel
|
| 7 |
Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib
|
Lamarca, A.
|
|
|
19 |
3 |
p. 364-372
|
artikel
|
| 8 |
Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007
|
Marcos-Gragera, R.
|
|
2016
|
19 |
3 |
p. 301-316
|
artikel
|
| 9 |
Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study
|
Casas, F.
|
|
2016
|
19 |
3 |
p. 373-378
|
artikel
|
| 10 |
Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery
|
Arredondo, J.
|
|
2016
|
19 |
3 |
p. 379-385
|
artikel
|
| 11 |
M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC
|
Chu, T.
|
|
2016
|
19 |
3 |
p. 326-331
|
artikel
|
| 12 |
New clinical trials regulation in Spain: analysis of royal decree 1090/2015
|
Martin Jimenez, M.
|
|
2016
|
19 |
3 |
p. 291-300
|
artikel
|
| 13 |
Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors
|
Carmona-Bayonas, A.
|
|
2016
|
19 |
3 |
p. 386-395
|
artikel
|
| 14 |
Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)
|
Kentepozidis, N.
|
|
2016
|
19 |
3 |
p. 317-325
|
artikel
|
| 15 |
Thanks to reviewers
|
|
|
2017
|
19 |
3 |
p. 396-398
|
artikel
|
| 16 |
The oncology day hospital in Spain: an updated analysis of Spanish Society of Medical Oncology (SEOM) looking forward
|
Jara, C.
|
|
2017
|
19 |
3 |
p. 269-272
|
artikel
|
| 17 |
Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
|
Chen, S.
|
|
2016
|
19 |
3 |
p. 332-340
|
artikel
|
Tijdschrift beschrijving